Orladeyo
These highlights do not include all the information needed to use ORLADEYO safely and effectively. See full prescribing information for ORLADEYO. ORLADEYO (berotralstat) capsules, for oral use Initial U.S. Approval: 2020
3527ece1-e7e0-40b1-b0c5-6baeb0deabeb
HUMAN PRESCRIPTION DRUG LABEL
Nov 29, 2023
BioCryst Pharmaceuticals Inc.
DUNS: 618194609
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Berotralstat hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Berotralstat hydrochloride
Product Details
FDA regulatory identification and product classification information